Cargando…
SARS-CoV-2 spike E484K mutation reduces antibody neutralisation
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026167/ https://www.ncbi.nlm.nih.gov/pubmed/33846703 http://dx.doi.org/10.1016/S2666-5247(21)00068-9 |
| _version_ | 1783675623454015488 |
|---|---|
| author | Jangra, Sonia Ye, Chengjin Rathnasinghe, Raveen Stadlbauer, Daniel Krammer, Florian Simon, Viviana Martinez-Sobrido, Luis García-Sastre, Adolfo Schotsaert, Michael |
| author_facet | Jangra, Sonia Ye, Chengjin Rathnasinghe, Raveen Stadlbauer, Daniel Krammer, Florian Simon, Viviana Martinez-Sobrido, Luis García-Sastre, Adolfo Schotsaert, Michael |
| author_sort | Jangra, Sonia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8026167 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Author(s). Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80261672021-04-08 SARS-CoV-2 spike E484K mutation reduces antibody neutralisation Jangra, Sonia Ye, Chengjin Rathnasinghe, Raveen Stadlbauer, Daniel Krammer, Florian Simon, Viviana Martinez-Sobrido, Luis García-Sastre, Adolfo Schotsaert, Michael Lancet Microbe Correspondence The Author(s). Published by Elsevier Ltd. 2021-07 2021-04-07 /pmc/articles/PMC8026167/ /pubmed/33846703 http://dx.doi.org/10.1016/S2666-5247(21)00068-9 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Jangra, Sonia Ye, Chengjin Rathnasinghe, Raveen Stadlbauer, Daniel Krammer, Florian Simon, Viviana Martinez-Sobrido, Luis García-Sastre, Adolfo Schotsaert, Michael SARS-CoV-2 spike E484K mutation reduces antibody neutralisation |
| title | SARS-CoV-2 spike E484K mutation reduces antibody neutralisation |
| title_full | SARS-CoV-2 spike E484K mutation reduces antibody neutralisation |
| title_fullStr | SARS-CoV-2 spike E484K mutation reduces antibody neutralisation |
| title_full_unstemmed | SARS-CoV-2 spike E484K mutation reduces antibody neutralisation |
| title_short | SARS-CoV-2 spike E484K mutation reduces antibody neutralisation |
| title_sort | sars-cov-2 spike e484k mutation reduces antibody neutralisation |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026167/ https://www.ncbi.nlm.nih.gov/pubmed/33846703 http://dx.doi.org/10.1016/S2666-5247(21)00068-9 |
| work_keys_str_mv | AT jangrasonia sarscov2spikee484kmutationreducesantibodyneutralisation AT yechengjin sarscov2spikee484kmutationreducesantibodyneutralisation AT rathnasingheraveen sarscov2spikee484kmutationreducesantibodyneutralisation AT stadlbauerdaniel sarscov2spikee484kmutationreducesantibodyneutralisation AT sarscov2spikee484kmutationreducesantibodyneutralisation AT krammerflorian sarscov2spikee484kmutationreducesantibodyneutralisation AT simonviviana sarscov2spikee484kmutationreducesantibodyneutralisation AT martinezsobridoluis sarscov2spikee484kmutationreducesantibodyneutralisation AT garciasastreadolfo sarscov2spikee484kmutationreducesantibodyneutralisation AT schotsaertmichael sarscov2spikee484kmutationreducesantibodyneutralisation |